JCM Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schmitt, M.
Right arrow Articles by Waterboer, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schmitt, M.
Right arrow Articles by Waterboer, T.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, February 2006, p. 504-512, Vol. 44, No. 2
0095-1137/06/$08.00+0     doi:10.1128/JCM.44.2.504-512.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Bead-Based Multiplex Genotyping of Human Papillomaviruses

Markus Schmitt,1* I. G. Bravo,1 Peter J. F. Snijders,2 Lutz Gissmann,1 Michael Pawlita,1 and Tim Waterboer1

Research Program Infection and Cancer, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 242, 69120 Heidelberg, Germany,1 Section Molecular Pathology, Department of Pathology, Vrije University Medical Center (VUMC), De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands2

Received 2 September 2005/ Returned for modification 2 November 2005/ Accepted 18 November 2005

Typing of human papillomaviruses (HPV) by DNA hybridization procedures, such as reverse line blot (RLB) assay, is sensitive and well validated. However, the application of these assays to high-throughput analyses is limited. Here, we describe the development of multiplex human papillomavirus genotyping (MPG), a quantitative and sensitive high-throughput procedure for the identification of multiple high- and low-risk genital HPV genotypes in a single reaction. MPG is based on the amplification of HPV DNA by a general primer PCR (GP5+/6+) and the subsequent detection of the products with type-specific oligonucleotide probes coupled to fluorescence-labeled polystyrene beads (Luminex suspension array technology). Up to 100 different HPV types can be detected simultaneously with MPG, and the method is fast and labor saving. We detected all 22 HPV types examined with high specificity and reproducibility (the median interplate coefficient of variation was below 10%). Detection limits for the different HPV types varied between 100 and 800 pg of PCR products. We compared the performance of MPG to an established RLB assay on GP5+/6+-PCR products derived from 94 clinical samples. The evaluation showed an excellent agreement (kappa = 0.922) but also indicated a higher sensitivity of MPG. In conclusion, MPG appears to be highly suitable for large-scale epidemiological studies and vaccination trials as well as for routine diagnostic purposes.


* Corresponding author. Mailing address: Research Program Infection and Cancer, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 242, 69120 Heidelberg, Germany. Phone: 49-6221-424937. Fax: 49-6221-424932. E-mail: markus.schmitt{at}dkfz.de.


Journal of Clinical Microbiology, February 2006, p. 504-512, Vol. 44, No. 2
0095-1137/06/$08.00+0     doi:10.1128/JCM.44.2.504-512.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2006 by the American Society for Microbiology. All rights reserved.